Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Unauthorised Transaction Due To Third Party Breach: Bank Customer Has Zero Liability, Says Bombay...

Unauthorised Transaction Due To Third Party Breach: Bank Customer Has Zero Liability, Says Bombay...

Aadhaar Card Update Deadline Extended: UIDAI Offers Free Corrections Until September 14; Here's What...

Aadhaar Card Update Deadline Extended: UIDAI Offers Free Corrections Until September 14; Here's What...

Bain Capital, BNP Paribas Sell 3.5% Stake In L&T Finance For ₹1,504 Crore

Bain Capital, BNP Paribas Sell 3.5% Stake In L&T Finance For ₹1,504 Crore

Reliance Capital Resolution: NCLT To Hear IIHL Plea For Deadline Extension On June 20

Reliance Capital Resolution: NCLT To Hear IIHL Plea For Deadline Extension On June 20

AI Innovations In Banking: Lessons Learned From Bhargava Kumar's Pioneering Projects

AI Innovations In Banking: Lessons Learned From Bhargava Kumar's Pioneering Projects